Syntho Pharmaceuticals Recalls EEMT HS Tablets Due to Sub-Potency
Syntho Pharmaceuticals is recalling 5,000 bottles of EEMT HS tablets due to sub-potency and cGMP violations. The product was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Syntho Pharmaceuticals, Inc. is recalling 5,000 bottles of EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg tablets. The recall is due to sub-potency and current Good Manufacturing Practice (cGMP) violations. The affected product is identified by Lot # S16E01 with an expiration date of 05/18.
The product was sold to the firm's sole distributor, who further distributed it throughout the United States. EEMT HS is a prescription-only medication manufactured by Syntho Pharmaceuticals, Inc., in Farmingdale, NY, and distributed by Creekwood Pharmaceutical, Inc., in Birmingham, AL.
Consumers and healthcare providers should stop using the recalled product and return it to the pharmacy or point of purchase. Patients should contact their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-020-01
- Manufacturer
- Syntho Pharmaceuticals, Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 5,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: S16E01
- Exp 05/18
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Syntho Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Syntho Pharmaceuticals, Inc.
See all →- ModerateSyntho Recalls EEMT Tablets Due to Sub-Potency and cGMP Violations
FDA (Drugs) · 2019-01-23
Same hazard · sub potency
See all →- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- HighLorazepam tablets recalled due to failed potency and impurity specifications
FDA (Drugs) · 2025-02-26
- HighLorazepam Tablets Recalled for Failed Impurity and Potency Specifications
FDA (Drugs) · 2025-02-26
- LowSinuFrin Nasal Decongestant Recalled for Sub-Potency Nationwide
FDA (Drugs) · 2024-07-03
- SeverePrescription Drug Javygtor Recalled for Sub-Potency and Powder Discoloration
FDA (Drugs) · 2024-05-15